If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where John Sweetenham is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A Better Pathway? Building Consensus and Engaging Providers with Feedback to Improve and Standardize Cancer Care

Colonna, S., Sweetenham, J., Burgon, T. B., Buys, S. S., Lynch, R., Au, T., Johnson, E., Kubal, T., Paculdo, D., Acelajado, M. C. & Peabody, J. W., Apr 2019, In : Clinical breast cancer. 19, 2, p. e376-e384

Research output: Contribution to journalArticle

  • 2 Scopus citations

    Implementing an electronic end-of-life chemotherapy utilization measure

    Kraut, J., Mooney, K., Sweetenham, J. W., Page, R. D., Adelson, K., Agarwala, V., Fessele, K. L., James Hamrick, H., Kaganman, I., Martineau, J., Abernethy, A. P. & Meropol, N. J., Apr 1 2019, In : Journal of oncology practice. 15, 4, p. 220-223 4 p.

    Research output: Contribution to journalReview article

    1 Scopus citations

    A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma

    Hill, B. T., Smith, M. R., Shelley, M., Jagadeesh, D., Dean, R. M., Pohlman, B., Sweetenham, J. W., Bolwell, B. J. & Smith, S. D., Mar 4 2018, In : Leukemia and Lymphoma. 59, 3, p. 690-694 5 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse

    Moskowitz, C. H., Walewski, J., Nademanee, A., Masszi, T., Agura, E., Holowiecki, J., Abidi, M. H., Chen, A. I., Stiff, P., Viviani, S., Bachanova, V., Sureda, A., McClendon, T., Lee, C., Lisano, J. & Sweetenham, J., Dec 20 2018, In : Blood. 132, 25, p. 2639-2642 4 p.

    Research output: Contribution to journalArticle

  • 29 Scopus citations

    Safety Analysis of Brentuximab Vedotin from the Phase III AETHERA Trial in Hodgkin Lymphoma in the Post-Transplant Consolidation Setting

    Nademanee, A., Sureda, A., Stiff, P., Holowiecki, J., Abidi, M., Hunder, N., Pecsok, M., Uttarwar, M., Purevjal, I. & Sweetenham, J., Nov 2018, In : Biology of Blood and Marrow Transplantation. 24, 11, p. 2354-2359 6 p.

    Research output: Contribution to journalArticle

    Open Access
  • 5 Scopus citations